FUJIFILM Diosynth Biotechnologies has announced the launch of its new mammalian expression platform, which it has named ‘Apolloâ„¢’. The platform is designed to create a robust ‘manufacturing-ready’ cell line and consists of four key components: a new CHO DG44-derived host cell line; a novel expression vector; a cell line development process, utilizing state of the art screening technologies and optimized media and feed components. FUJIFILM Diosynth Biotechnologies has demonstrated that this combination leads to a high producing recombinant cell line…